Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0002024096-26-000002

Chief Operating Officer acquired 65,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Otero Jose Manuel · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-04 Grant or award : show line 1 in the form +65,000 128,476 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-04 Grant or award : show line 2 in the form Stock Option (right to buy) +260,000 260,000 D
Loading xslF345X05/form4-02062026_050203.xml…